
Maciej Bochenek
Orthopedic physician. Specializing in the shoulder, elbow, hand and wrist. He accepts appointments in Poznan. His interests are mainly in upper limb ailments, including nerve and tendon diseases, overload syndromes, degenerative diseases or injuries, including sports injuries.
- Description
Doctor Maciej Bochenek is a specialist in orthopedics and traumatology of the musculoskeletal system, with a special interest in upper limb ailments, including nerve and tendon diseases, overload syndromes, degenerative diseases or injuries, including sports injuries. He also treats pediatric orthopedics for congenital malformations and traumatology of the upper limb.
He tries to start treatment with non-operative methods, taking into account the use of profiled physiotherapy. In situations requiring surgical treatment, he offers a wide range of operations within the upper limb or peripheral nerve diseases of the entire body.
The doctor deals with:
Medical consultation for the shoulder, elbow, hand and wrist.
Education:
Graduate of the K. Marcinkowski Medical University in Poznan. Resident in the final year of Orthopedics and Traumatology of the musculoskeletal system. Doctoral dissertation in medical sciences entitled. "Assessment of musculoskeletal loads in the upper limbs and their rims among professional violinists".
Professional practice:
- Work in the Department of Traumatology, Orthopedics and Hand Surgery of the Orthopedic and Rehabilitation Clinical Hospital in Poznan.
- Foreign internships at the Universitätsklinikum in Halle (Saale) and the High Technology Medical Center in Tbilisi
- Kaplan Institute, Barcelona, Spain
Training and courses:
Attended courses in arthroscopy, microsurgery and bone anastomosis.
Awards:
- 2nd prize at the 14th International Congress of Young Medical Scientists for the paper "The Impact of high dose chemotherapy on response improvement in patients with multiple myeloma".
- 3rd prize at the 15th International Congress of Young Medical Scientists for the paper "PSME1 and TXNDC5 as a potential prognostic parameters in treatment of patients with resistant multiple myeloma".